blinatumomab
amgen
['leusm', 'blinatumomab']
congress #eha2023 |shaun fleming presents final results of ph ii poc (allg all8) study. blinatumomab+reduced intensity chemotherapy was feasible &amp; well tolerated in pts with ph- b-all. cr was attained in 29/30 pts. 24-month efs was 60.4%.
#leusm #allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm